Matthew J. D'Onofrio - Aug 7, 2024 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role: Chief Executive Officer, Director
Signature: /s/ Matthew J. D'Onofrio
Stock symbol: EVOK
Transactions as of: Aug 7, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/8/2024, 04:48 PM
Previous filing: Feb 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVOK	Stock Option (Right to Buy)	Award	$0	+64.8K		$0.00	64.8K	Aug 7, 2024	Common Stock	64.8K	$5.27	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	50% of the total number of shares subject to the options shall vest on the 18th month anniversary of August 7, 2024 (the "Vesting Commencement Date"), and 1/36th of the other 50% of the total number of shares subject to the options shall vest on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.

Content

50% of the total number of shares subject to the options shall vest on the 18th month anniversary of August 7, 2024 (the "Vesting Commencement Date"), and 1/36th of the other 50% of the total number of shares subject to the options shall vest on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.